Abstract
Objective
To evaluate the efficacy of single oral mega-dose of Vitamin D3 for treatment and prevention of pneumonia in underfive children.
Design
Randomized, double blind, placebo-controlled trial.
Setting
Tertiary-care hospital.
Participants
324 children (of 980 assessed) between 6 mo-5 y age (median (IQR): 12 (7,19.8) mo) with WHO-defined severe pneumonia. Of these, 126 (39%) were vitamin D deficient (serum 25(OH)D <12 ng/mL).
Intervention
100,000 IU of oral cholecalciferol (n= 162) or placebo (n= 162) in single dose, administered at enrolment.
Outcome variables
Primary: Time to resolution of severe pneumonia and proportion of children having recurrence of pneumonia in next 6 months; Secondary: Change in serum levels of 25(OH)D; immunoglobulins IgA, IgG, IgM, and cathelicidin 2 weeks following supplementation; and time taken for overall resolution of illness.
Results
Median (95% CI) time for resolution of severe pneumonia was 30 (29, 31) h in the vitamin D group as compared to 31 (29,33) h in the placebo group [adjusted hazard ratio (95% CI): 1·39 (1·11, 1·76); P=0·005]. The risk of recurrence of pneumonia in next 6 months was comparable in the two groups [placebo: 36/158 (22·8%); vitamin D: 39/156 (25%); RR (95% CI): 1·13 (0·67,1·90); P=0·69]. Proportion of vitamin D deficient children declined from 38% to 4% in the supplementation group, and from 41% to 33% in the placebo group, two weeks after supplementation. There was no significant effect of vitamin D supplementation on serum levels of cathelicidin, IgA and IgG. The time taken for complete recovery from pneumonia, duration of hospitalization, and fever clearance time were comparable for the two groups. No adverse event was noted related to the intervention.
Conclusion
There is no robust evidence of a definite biological benefit, either for therapy or prevention, to suggest a routine megadose supplement of vitamin D3 for under-five children with severe pneumonia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
World Health Organization. Pneumonia fact sheet N 331. From http://www.who.int/mediacentre/factsheets/fs331/en. Accessed January 23, 2016.
McNally JD, Leis K, Matheson LA, Karuananyake C, Sankaran K, Rosenberg AM. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol. 2009;44:981–8.
Roth DE, Shah R, Black RE, Baqui AH. Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr. 2010;99:389–93.
Karatekin G, Kaya A, Saliho Églu O, Balci H, NuhoÉglu A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009;63:473–7.
Ahmed P, Babaniyi IB, Yusuf KK, Dodd C, Langdon G, Steinhoff M, Dawodu A. Vitamin D status and hospitalization for childhood acute lower respiratory tract infections in Nigeria. Paediatr Int Child Health. 2015; 35:151–6.
Shah N, Ramankutty V, Premila PG, Sathy N. Risk factors for severe pneumonia in children in south Kerala: a hospital-based case-control study. J Trop Pediatr. 1994;40:201–6.
Banajeh SM. Nutritional rickets and vitamin D deficiencyassociation with the outcomes of childhood very severe pneumonia: A prospective cohort study. Pediatr Pulmonol. 2009;44:1207–15.
Wayse V, Yousafzai A, Mogale K, Filteau S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. Eur J Clin Nutr. 2004;58:563–7.
Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.
Muhe L, Lulseged S, Mason KE, Simoes EAF. Case control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet. 1997;349:1801–4.
Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91:1255–60.
Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127:1294–6.
Camargo CA Jr, Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ, Kleinman K, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130:e561–7.
Manaseki-Holland S, Qader G, Isaq Masher M, Bruce J, Zulf Mughal M, Chandramohan D, et al. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomized controlled trial. Trop Med Int Health. 2010;15:1148–55.
Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomized controlled superiority trial. Lancet. 2012;379:1419–27.
Choudhary N, Gupta P. Vitamin D supplementation for severe pneumonia-a randomized controlled trial. Indian Pediatr. 2012;49:449–54.
Charan J, Goyal JP, Saxena D, Yadav P. Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis. J Pharmacol Pharmacother. 2012;3:300–3.
World Health Organization. Technical bases for the WHO Recommendations on the Management of Pneumonia in Children at First level Health Care. Report no. WHO/ARI/91·20. Geneva: WHO; 1995.
WHO Child and Adolescent Health and Development (CAH). Integrated management of neonatal and childhood illness and HIV. Physician Chart Booklet. New Delhi: Ministry of Health and Family Welfare, Govt. of India; 2007.
World Health Organization. Physical status: The Use and Interpretation of Anthropometry. Report of WHO Expert Committee. Geneva: WHO; 1987.
World Health Organization Anthro for personal computers, version 3·2·2, 2011: Software for assessing growth and development of the world’s children. Geneva: WHO; 2010. http://www.who.int/childgrowth/software/en/(accessed September 2011).
World Health Organization, Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. Geneva: World Health Organization; 2006.
Agarwal R, Singh V, Yewale V. RTI Facts. Indian Academy of Pediatrics Consensus Guidelines on Rational Management of Respiratory Tract Infections in Children. Mumbai: Indian Academy of Pediatrics; 2006.
Institute of Medicine Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press; 2011.
Nicholson JF, Pesce MA. Reference ranges for laboratory tests and procedures. In: Behrman RE, Kliegman RM, editors. Nelson Textbook of Pediatrics. 17th edition. Philadelphia: Saunders; 2003 P 2396–427.
Hollick MF. The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep. 2006;4:96–102.
Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells; presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983;57:1308–10.
Provvedini DM, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 promotes in vitro morphologic and enzymatic changes in normal human monocytes consistent with their differentiation into macrophages. Bone. 1986;7:23–8.
Pletz MW, Terkamp C, Schumacher U, Rohde G, Schütte H, Welte T, et al; CAPNETZ-Study Group. Vitamin D deficiency in community acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respir Res. 2014;15:53.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gupta, P., Dewan, P., Shah, D. et al. Vitamin D supplementation for treatment and prevention of pneumonia in under-five children: A randomized double-blind placebo controlled trial . Indian Pediatr 53, 967–976 (2016). https://doi.org/10.1007/s13312-016-0970-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-016-0970-5